Wordt geladen...
Maximizing Safety in the Conduct of Alzheimer’s Disease Fluid Biomarker Research in the Era of COVID-19
The coronavirus disease 2019 (COVID-19) pandemic led to an abrupt halt of many Alzheimer’s disease (AD) research studies at sites spanning the world. This is especially true for studies requiring in-person contact, such as studies collecting biofluids. Since COVID-19 is likely to remain a threat for...
Bewaard in:
| Gepubliceerd in: | J Alzheimers Dis |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995336/ https://ncbi.nlm.nih.gov/pubmed/32568212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200684 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|